06 March 2026

Champalimaud Foundation and Universidade Católica Portuguesa establish partnership to strengthen biomedical research in Portugal

The agreement establishes a long-term framework for collaboration between the two institutions, creating a model that brings university research closer to one of the country’s most advanced scientific infrastructures while fostering the development of new joint initiatives in biomedicine and interdisciplinary research.

Champalimaud Open Seminar (COpS)

Title to be announced

Leopoldo Petreanu, Cortical Circuits
 

"From Clinical Questions to Research Answers: The Immune Microenvironment of Multiple Myeloma and New Immunotherapy Opportunities"

Cristina João, Myeloma Lymphoma Research Group
 

Moderation

Henrique Veiga-Fernandes, Immunophysiology

04 March 2026

Can the brain sense cancer? Up to $25M awarded to a team including the Champalimaud Foundation to explore a new frontier in oncology

Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.

Differentiation and Maintenance of Exhausted and Tissue Resident CD8 T cells

Host

Klaas Vangisbergen, PhD, Tissue Immunity Lab


Venue

Seminar Room

27 February 2026

Champalimaud Foundation’s brand reputation over time: results, context, and reflection

Brand rankings and reputation studies are published every year, nationally and internationally, often attracting attention for their league tables and headline positions. While such studies are inevitably shaped by methodological choices, sampling criteria, and contextual factors, they can nonetheless offer a useful lens for understanding how organisations are perceived within a shared ecosystem.

Medica AI 2026

Healthcare is entering a decisive decade.

Artificial Intelligence (AI) is no longer a promise on the horizon – it is already transforming diagnostics, treatment, research, education and health systems worldwide. The real challenge we now face is not whether AI will change healthcare, but how we design that transformation responsibly, sustainably and at scale.

PATEO – Pessoas com Autonomia, Tecto, Espaço e Oportunidade

Date and Time

27 March 2026, 2:30pm – 6:30pm

Location

Auditorium, Champalimaud Foundation, Lisbon

About

PATEO is a Science4Policy project that translates scientific evidence on the prevention of dementia and age-related functional decline into concrete, actionable solutions to support healthier aging, greater autonomy and improved quality of life.

International Rectal Cancer Meeting

Fifty years ago, Total Mesorectal Excision (TME) transformed rectal cancer surgery, improving local control, survival and quality of life worldwide.

On 22–23 May 2026, the International Rectal Cancer Meeting - “50 Years of Total Mesorectal Excision: Celebrating the Legacy of Bill Heald” will bring leading experts to the Champalimaud Centre for the Unknown in Lisbon to mark this milestone and explore what lies ahead.
 

Cytokine–Microbiota Circuits in Gut Development and Regeneration: Insights from Zebrafish

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab


Venue

Seminar Room

28 Jan. 2026

Technician (Preclinical MRI Lab)

Research
Application Starts: 28 Jan. 2026

 

[THIS CALL IS NOW CLOSED]

 

Subscribe to Cancer
Loading
Please wait...